首页 > 市场调查报告书 > 医疗设备

北美脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）

市场调查报告书

商品编码

1463657

北美脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）

North America Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日期: 2024年01月22日 | 出版商:

The Insight Partners | 英文 80 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美脑脊髓液管理市值为8.0796亿美元，预计2030年将达到12.4249亿美元；预计2022年至2030年CAGR为5.5%。

脑脊髓液洩漏病例的增加推动了北美脑脊髓液管理市场的发展

根据《神经外科杂誌》报道，全球每年估计有超过 6,900 万人遭受脑外伤。脑部和脊椎损伤是成人脑脊髓液 (CSF) 渗漏最常见的原因，因此需要进行脑脊髓液处理。高血压主要是由于生活方式的改变和不健康习惯引起的，是成人和老年人脑脊髓液漏的另一个显着原因。同样，高血压在老年人中很常见，这最终导致特发性颅内高压（IIH）的风险增加。因此，老年人口的成长可能与北美脑脊髓液管理市场的成长有关。

世界各地脑积水的发生率正在显着增加。脑积水的发生率在老年族群最高；值得注意的是，与成人相比，儿科族群的发生率更高。根据国家医学图书馆 (NLM) 发表的一篇文章，全球脑积水盛行率约为每 10 万人中 85 人。根据同一来源，儿科族群的盛行率约为每 10 万人 11 人，老年人口的盛行率约为每 10 万人 175 人。此外，低收入和中等收入国家的脑积水发生率为每 10 万名新生儿约 123 例，而高收入国家的发生率为每 10 万名新生儿 79 例。脑脊髓液分流和引流系统是适合所有年龄层诊断的脑积水病例的治疗选择。因此，脑脊髓液洩漏病例的增加促进了北美脑脊髓液管理市场的成长。

北美脑脊髓液管理市场概况

北美脑脊髓液管理市场分为美国、加拿大和墨西哥。美国在该地区占有最大的市场份额。由于脑积水、创伤性脑损伤和其他神经系统疾病发病率的增加，预计该地区的市场在预测期内将继续占据主导地位；快速的技术创新；和发展医疗保健基础设施。

北美脑脊髓液管理市场收入及 2030 年预测（百万美元）

北美脑脊髓液管理市场细分

北美脑脊髓液管理市场分为产品、最终用户和国家。

根据产品，北美脑脊髓液管理市场分为脑脊髓液分流器和脑脊髓液引流系统。 2022 年，CCS 分流器细分市场将占据更大的市场。

根据最终用户，北美脑脊髓液管理市场分为医院、诊所、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

依国家/地区划分，北美脑脊髓液管理市场分为美国、加拿大和墨西哥。 2022年，美国在北美脑脊髓液管理市场占有率中占据主导地位。

Argi Group Health Services Ltd Sti、B. Braun SE、BeckerSmith Medical Inc、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc、Sophysa SA 和 Spiegelberg GmbH & Co KG 是北美脑脊髓液领域的一些领先公司管理市场。

According to the Journal of Neurosurgery, more than 69 million people globally are estimated to suffer from traumatic brain injuries annually. Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leaks in adults, necessitating CSF management. High blood pressure, majorly caused due to a shift in lifestyle and unhealthy habits, is another notable cause of CSF leaks among adults and elderlies. Similarly, high blood pressure is common in elderly people, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH). Thus, the growing geriatric population can be associated with the growth of the North America cerebrospinal fluid management market.

The incidence of hydrocephalus is growing significantly across the world. The occurrence of hydrocephalus is highest in the geriatric population; notably, it is higher in the pediatric population compared to adults. According to an article published by the National Library of Medicine (NLM), the global prevalence of hydrocephalus is ~85 per 100,000 individuals. Per the same source, the prevalence rate in the pediatric population is ~88 per 100,000 whereas the rate is ~11 per 100,000 in adults and ~175 per 100,000 in the geriatric population. Further, the incidence rate of hydrocephalus in low- and medium-income countries is ~123 per 100,000 births whereas the rate in high-income countries is 79 per 100,000 births. The CSF shunts and drainage systems are the treatment options suitable for hydrocephalus cases diagnosed in people from all age groups. Hence, an increase in CSF leak cases boosts the growth of the North America cerebrospinal fluid management market.

North America Cerebrospinal Fluid Management Market Overview

The North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in this region. The market in this region is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure.

North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

North America Cerebrospinal Fluid Management Market Segmentation

The North America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the North America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the North America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US dominated the North America cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, BeckerSmith Medical Inc, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the North America cerebrospinal fluid management market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Cerebrospinal Fluid Management Market Landscape

4.1 Overview
4.2 North America PEST Analysis

5. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
- 5.1.2 Developments in CSF Management Products
5.2 Market Restraints
- 5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
- 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
- 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - North America Market Analysis

6.1 North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Ventriculoperitoneal Shunts
  - 7.3.3.1 Overview
  - 7.3.3.2 Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Ventriculoatrial Shunts
  - 7.3.4.1 Overview
  - 7.3.4.2 Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Ventriculopleural Shunts
  - 7.3.5.1 Overview
  - 7.3.5.2 Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Lumboperitoneal Shunts
  - 7.3.6.1 Overview
  - 7.3.6.2 Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 External Ventricular Drainage (EVD) Systems
  - 7.4.3.1 Overview
  - 7.4.3.2 External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
  - 7.4.4.1 Overview
  - 7.4.4.2 Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Cerebrospinal Fluid Management Market - Country Analysis

9.1 Overview

10. North America Cerebrospinal Fluid Management Market -Industry Landscape

10.1 Overview
10.2 Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 B. Braun SE
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Argi Group Health Services Ltd Sti
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Sophysa SA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BeckerSmith Medical Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Natus Medical Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Spiegelberg GmbH & Co KG
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Cerebrospinal Fluid Management Market Segmentation
Table 2. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 3. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 4. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 5. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 6. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 7. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 8. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 9. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 10. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 11. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 12. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 13. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Recent Inorganic Growth Strategies in the North America Cerebrospinal Fluid Management Market
Table 15. Recent Organic Growth Strategies in The North America Cerebrospinal Fluid Management Market
Table 16. Glossary of Terms, North America Cerebrospinal Fluid Management Market

List Of Figures

Figure 1. North America Cerebrospinal Fluid Management Market Segmentation, By Country
Figure 2. North America - PEST Analysis
Figure 3. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
Figure 6. North America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
Figure 7. North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
Figure 17. Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
Figure 22. North America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
Figure 23. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023